LeonaBio (LONA) Payables (2019 - 2026)
LeonaBio (LONA) reported Payables of $1.8 million for Q1 2026, up 103.46% year-over-year from $867000.0 in Q1 2025, and down 61.54% on a QoQ basis from $4.6 million in Q4 2025.
LeonaBio (LONA) has 8 years of Payables data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Payables rose 103.46% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 103.46% YoY) and the FY2025 annual result came in at $4.6 million, up 1337.93% from the prior year.
- Payables fell to $1.8 million in Q1 2026 per LONA's latest filing, from $4.6 million in the prior quarter.
- Across five years, Payables topped out at $4.6 million in Q4 2025 and bottomed at $129000.0 in Q4 2023.
- The 5-year median for Payables is $681000.0 (2024), against an average of $1.1 million.
- The widest annual swing landed in 2023, when Payables sank 94.84%; it then soared 1337.93% in 2025.
- Tracing LONA's Payables over 5 years: stood at $2.5 million in 2022, then slumped by 94.84% to $129000.0 in 2023, then jumped by 147.29% to $319000.0 in 2024, then soared by 1337.93% to $4.6 million in 2025, then slumped by 61.54% to $1.8 million in 2026.
- Per Business Quant, the three latest LONA Payables figures stand at $1.8 million (Q1 2026), $4.6 million (Q4 2025), and $266000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 266,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 681,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 612,000.00 |
| Mar 31, 2023 | 892,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 751,000.00 |
| Jun 30, 2022 | 605,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 959,000.00 |
| Jun 30, 2021 | 1.17 Mn |
| Mar 31, 2021 | 1.69 Mn |
| Dec 31, 2020 | 1.16 Mn |
| Sep 30, 2020 | 3.87 Mn |
| Dec 31, 2019 | 421,000.00 |